Puma Biotechnology (PBYI) Asset Writedowns and Impairment (2020 - 2025)
Puma Biotechnology (PBYI) posted Asset Writedowns and Impairment of $400000.0 for Q4 2025, up 500.0% on a QoQ basis from -$100000.0 in Q3 2025, and up 205.54% year-over-year from $130915.4 in Q4 2024.
Puma Biotechnology (PBYI) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends
Puma Biotechnology's Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $400000.0 for Q4 2025.
- Quarterly Asset Writedowns and Impairment rose 205.54% year-over-year to $400000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $213000.0 (up 136.79% YoY) and the FY2024 annual result came in at -$500000.0, down 156.75% from the prior year.
- Asset Writedowns and Impairment was $400000.0 for Q4 2025 at Puma Biotechnology, up from -$100000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $514000.0 in Q2 2023 and bottomed at -$379000.0 in Q4 2024.
- A 3-year average of $51500.0 and a median of $0.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment tumbled 203.27% — and 2025, when it jumped 205.54%.
- Puma Biotechnology's Asset Writedowns and Impairment stood at $367000.0 in 2023, then tumbled by 203.27% to -$379000.0 in 2024, then soared by 205.54% to $400000.0 in 2025.
- Business Quant data shows PBYI's Asset Writedowns and Impairment at $400000.0 in Q4 2025, -$100000.0 in Q3 2025, and -$300000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Puma Biotechnology | 409.56 Mn | 371.27 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | -100,000.00 |
| Sep 30, 2025 | -100,000.00 |
| Jun 30, 2025 | -300,000.00 |
| Jun 30, 2025 | -300,000.00 |
| Mar 31, 2025 | 213,000.00 |
| Mar 31, 2025 | 213,000.00 |
| Dec 31, 2024 | -379,000.00 |
| Dec 31, 2024 | -379,000.00 |
| Sep 30, 2024 | -100,000.00 |
| Sep 30, 2024 | -100,000.00 |
| Jun 30, 2024 | -200,000.00 |
| Jun 30, 2024 | -200,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 367,000.00 |
| Dec 31, 2023 | 367,000.00 |
| Jun 30, 2023 | 514,000.00 |
| Jun 30, 2023 | 514,000.00 |